Leflunomide induced acute interstitial pneumonia

Journal of Rheumatology

Volumn 32, Issue 6, 2005, Pages 1160-1163

  Takeishi, Michio ^a   Akiyama, Yuji ^a   Akiba, Haruhiko ^a   Adachi, Daisuke ^a   Hirano, Motoharu ^a   Mimura, Toshihide ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cholestyramine; Interstitial pneumonia; Leflunomide; Rheumatoid arthritis

Indexed keywords

COLESTYRAMINE; DICLOFENAC; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LEFLUNOMIDE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ACUTE RESPIRATORY FAILURE; ADULT; ARTICLE; BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; HYPERTENSION; INTERSTITIAL PNEUMONIA; JAPAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY;

ADJUVANTS, IMMUNOLOGIC; ARTHRITIS, RHEUMATOID; CHOLESTYRAMINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISOXAZOLES; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; PREDNISOLONE; RADIOGRAPHY, THORACIC; TREATMENT OUTCOME;

EID: 20444480959     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Breedveld FC, Dayer JM. Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis 2000;59:841-9.
2. Strand V, Cohen S, Schiff M, et al, for the Leflunomide Rheumatoid Arthritis Investigators Group. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 1999;159:2542-50.
3. Smolen JS, Kalden JR, Scott DL, et al, for the European Leflunomide Study Group. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomized, multicentre trial. Lancet 1999;353:259-66.
4. Emery P, Breedveld FC, Lemmel EM, et al. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology Oxford 2000;39:655-65.
5. Kalden JR, Schattenkirchner M, Sorensen H, et al. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year follow up study. Arthritis Rheum 2003;48:1513-20.
6. Siva C, Eisen SA, Shepherd R, et al. Leflunomide use during the first 33 months after Food and Drug Administration approval: experience with a national cohort of 3,325 patients. Arthritis Rheum 2003;49:745-51.
7. Li EK, Tam LS, Tomlinson B. Leflunomide in the treatment of rheumatoid arthritis. Clin Ther 2004;26:447-59.
8. Osiri M, Shea B, Robinson V, et al. Leflunomide for the treatment of rheumatoid arthritis: A systematic review and metaanalysis. J Rheumatol 2003;30:1182-90.
9. Van Roon EN, Jansen TL, Mourad L, et al. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice. Br J Clin Pharmacol 2004;57:790-7.
10. van Riel PLCM, Smolen JS, Emery P, et al. Leflunomide: a manageable safety profile. J Rheumatol 2004;31 Suppl 71:21-4.
11. Gabbay E, Tarala R, Will R, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997;156:528-35.
12. Dawson JK, Fewins HE, Desmond J, et al. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 2001;56:622-7.
13. Barrera P, Laan RFJM, van Riel PLCM, et al. Methotrexate-related pulmonary complications in rheumatoid arthritis. Ann Rheum Dis 1994;53:434-9.
14. Stenger AA, Houtman PM, Bruyn GA, et al. Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis. Scand J Rheumatol 1994;23:51-3.
15. Mladenovic V, Domljan Z, Rozman B, et al. Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled phase II study. Arthritis Rheum 1995;38:1595-603.
16. Alarcon GS. Methotrexate: Its use for the treatment of rheumatoid arthritis and other rheumatic disorders. In: Koopman WJ, editor. Arthritis and allied conditions. 14th ed. Baltimore: Williams & Wilkins; 2001:743-68.
17. McCurry J. Japan deaths spark concerns over arthritis drug. Lancet 2004;363:461.
18. Scott DL. Interstitial lung disease and disease modifying antirheumatic drugs. Lancet 2004;363:1239-40.
19. Ichikawa Y, Kamatani N, Goto M, et al. Phase II dose ranging study of leflunomide in Japan (Investigation of efficacy, safety and pharmacokinetics). J New Remed Clin 2003;52:15-57.